Publicaciones en colaboración con investigadores/as de Aarhus University Hospital (33)

2024

  1. Embolization of percutaneous left atrial appendage closure devices: timing, management and clinical outcomes

    Cardiovascular Revascularization Medicine

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Enasidenib vs conventional care in older patients with late-stage mutant-IDH2 relapsed/refractory AML: a randomized phase 3 trial

    Blood, Vol. 141, Núm. 2, pp. 156-167

  3. Impact of Device Implant Depth After Left Atrial Appendage Occlusion

    JACC. Cardiovascular interventions, Vol. 16, Núm. 17, pp. 2139-2149

  4. Symptomatic vs. non-symptomatic device-related thrombus after LAAC: a sub-analysis from the multicenter EUROC-DRT registry

    Clinical Research in Cardiology, Vol. 112, Núm. 12, pp. 1790-1799

2022

  1. Clinical and echocardiographic risk factors for device-related thrombus after left atrial appendage closure: an analysis from the multicenter EUROC-DRT registry

    Clinical Research in Cardiology, Vol. 111, Núm. 11, pp. 1276-1285

  2. Natural History of MYH7-Related Dilated Cardiomyopathy

    Journal of the American College of Cardiology, Vol. 80, Núm. 15, pp. 1447-1461

  3. The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee

    Blood, Vol. 140, Núm. 11, pp. 1229-1253

2021

  1. Alpha-protein kinase 3 (ALPK3) truncating variants are a cause of autosomal dominant hypertrophic cardiomyopathy

    European Heart Journal, Vol. 42, Núm. 32, pp. 3063-3073

  2. Chemotherapy and radiotherapy in locally advanced head and neck cancer: an individual patient data network meta-analysis

    The Lancet Oncology, Vol. 22, Núm. 5, pp. 727-736

  3. Comparative data on left atrial appendage occlusion efficacy and clinical outcomes by age group in the Amplatzer™ Amulet™ Occluder Observational Study

    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, Vol. 23, Núm. 2, pp. 238-246

  4. Device-Related Thrombus After Left Atrial Appendage Closure: Data on Thrombus Characteristics, Treatment Strategies, and Clinical Outcomes From the EUROC-DRT-Registry

    Circulation: Cardiovascular Interventions, Vol. 14, Núm. 5, pp. E010195

  5. Expression quantitative trait loci of genes predicting outcome are associated with survival of multiple myeloma patients

    International Journal of Cancer, Vol. 149, Núm. 2, pp. 327-336

  6. Genetically determined telomere length and multiple myeloma risk and outcome

    Blood Cancer Journal, Vol. 11, Núm. 4

  7. Left atrial appendage occlusion in chicken-wing anatomies: Imaging assessment, procedural, and clinical outcomes of the “sandwich technique”

    Catheterization and Cardiovascular Interventions, Vol. 97, Núm. 7, pp. E1025-E1032

  8. Toxic iron species in lower-risk myelodysplastic syndrome patients: course of disease and effects on outcome

    Leukemia, Vol. 35, Núm. 6, pp. 1745-1750

2020

  1. Left atrial appendage occlusion for stroke despite oral anticoagulation (resistant stroke). Results from the Amplatzer Cardiac Plug registry

    Revista Espanola de Cardiologia, Vol. 73, Núm. 1, pp. 28-34

  2. Procedural and Short-Term Results With the New Watchman FLX Left Atrial Appendage Occlusion Device

    JACC: Cardiovascular Interventions, Vol. 13, Núm. 23, pp. 2732-2741

  3. The Impact of CHA2DS2-VASc and HAS-BLED Scores on Clinical Outcomes in the Amplatzer Amulet Study

    JACC: Cardiovascular Interventions, Vol. 13, Núm. 18, pp. 2099-2108

  4. Value of FEops HEARTguide patient-specific computational simulations in the planning of left atrial appendage closure with the Amplatzer Amulet closure device: Rationale and design of the PREDICT-LAA study

    Open Heart, Vol. 7, Núm. 2